Now, let me be clear from the start
DSIP also demonstrates effects on the opioid system in the brain
This is the question that actually has clinical nuance, and where the practice youre working with starts to matter
Glutathione is an important antioxidant in the lungs, but its concentration is low in the airways of patients with cystic fibrosis, since GSH is transported into the airways by the cystic fibrosis transmembrane conductance regulator, which is mutated in cystic fibrosis patients (111)
This policy ensures that patients can confidently explore this antioxidant therapy, knowing they will not incur unnecessary costs if the treatment is unsuitable for their needs
If youre already prescribing, or considering it, the question is the same: how do you operate compliantly while the legal pathway is still being built